In this article

Pharmaceutical Pfizer Inc. said that an oral drug for treating COVID-19 could be available by end of 2021.
Soumyabrata Roy | NurPhoto | Getty Images

Pfizer on Tuesday reported first-quarter revenue and adjusted earnings that topped Wall Street’s expectations, despite a decline in sales driven by the lower demand for the company’s Covid vaccine.

Pfizer’s stock edged higher in premarket trading Tuesday. Shares are down more than 23% for the year through Monday’s close, putting the company’s market value at around $221.3 billion. 

Here’s what Pfizer reported compared with Wall Street’s expectations, based on a survey of analysts by Refinitiv:

  • Earnings per share: $1.23 adjusted, vs. 98 cents expected 
  • Revenue: $18.28 billion, vs. $16.59 billion expected

The company posted net income of $5.54 billion, or 97 cents per share. That compares with $7.86 billion, or $1.37 per share, for the same period a year ago.

The pharmaceutical giant reported first-quarter sales of $18.28 billion, down 29% over the same period a year ago.

Sales of the company’s Covid vaccine declined $10 billion, or 75% compared with the same quarter last year. Pfizer said this was primarily driven by lower contracted deliveries and demand in international markets.

The New York-based company maintained its 2023 sales forecast of $67 billion to $71 billion. Pfizer also reiterated its full-year adjusted earnings outlook of $3.25 to $3.45 per share.

Pfizer will hold an earnings call at 10:00 a.m. ET.

Read the earnings release.

This is a developing story. Check back for updates.

You May Also Like

Delta variant outbreak infects highly vaccinated prison population, but few were hospitalized, CDC says

A Sheriff’s deputy takes an employee’s temperature as at Las Colinas women’s…

Netflix founder Reed Hastings is giving up his CEO role

In this article NFLX Follow your favorite stocksCREATE FREE ACCOUNT Netflix co-founder…
Shein confidentially files for London IPO

Shein confidentially files for London IPO

Shein sign during its opening, at ABC Serrano, on 26 April, 2024…

Bill Gates slams U.S. on Covid: Most governments listen to their scientists, not attack them

Bill Gates CNBC Billionaire philanthropist Bill Gates criticized the U.S. response to…